Bromoxynil

Target genes for Bromoxynil is obtained based on ToxCast assay component endpoints.
Chemical nameGene identifierToxCast assay component endpoint name
BromoxynilCREB3ATG_CRE_CIS_up
BromoxynilCEBPBATG_C_EBP_CIS_up
BromoxynilCSF1BSK_LPS_MCSF_down
BromoxynilCSNK2A1NVS_ENZ_hCK2a2b2
BromoxynilCYP1A1CLD_CYP1A1_24hr
BromoxynilEGR1ATG_EGR_CIS_up
BromoxynilAHRTOX21_AhR_LUC_Agonist
BromoxynilAHRATG_Ahr_CIS_up
BromoxynilESR1ATG_ERE_CIS_up
BromoxynilESR1ATG_ERa_TRANS_up
BromoxynilESR1TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2
BromoxynilESR1TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2
BromoxynilESR2TOX21_ERb_BLA_Antagonist_ratio
BromoxynilESRRATOX21_ERR_Antagonist
BromoxynilESRRATOX21_PGC_ERR_Antagonist
BromoxynilETS1ATG_Ets_CIS_dn
BromoxynilFOSATG_AP_1_CIS_up
BromoxynilHLA-DRABSK_3C_HLADR_down
BromoxynilHLA-DRABSK_BE3C_HLADR_down
BromoxynilIL1ABSK_LPS_IL1a_up
BromoxynilCXCL8BSK_SAg_IL8_down
BromoxynilCXCL10BSK_hDFCGF_IP10_down
BromoxynilCXCL10BSK_BE3C_IP10_down
BromoxynilARTOX21_AR_BLA_Agonist_ratio
BromoxynilARTOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881
BromoxynilARTOX21_AR_LUC_MDAKB2_Agonist
BromoxynilARTOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881
BromoxynilARTOX21_AR_BLA_Antagonist_ratio
BromoxynilARACEA_AR_antagonist_80hr
BromoxynilJUNATG_AP_1_CIS_up
BromoxynilSMAD1ATG_BRE_CIS_up
BromoxynilMTF1ATG_MRE_CIS_up
BromoxynilNFIAATG_NFI_CIS_up
BromoxynilNFE2L2ATG_NRF2_ARE_CIS_up
BromoxynilNFE2L2TOX21_ARE_BLA_agonist_ratio
BromoxynilNTRK1NVS_ENZ_hTrkA
BromoxynilSERPINE1BSK_BE3C_PAI1_down
BromoxynilPGRTOX21_PR_BLA_Antagonist_ratio
BromoxynilABCB1CLD_ABCB1_48hr
BromoxynilPLAUBSK_BE3C_uPA_down
BromoxynilPLAURBSK_CASM3C_uPAR_down
BromoxynilPLAURBSK_3C_uPAR_down
BromoxynilPLAURBSK_4H_uPAR_down
BromoxynilPOU2F1ATG_Oct_MLP_CIS_up
BromoxynilPPARAATG_PPARa_TRANS_up
BromoxynilPPARAATG_PPRE_CIS_up
BromoxynilPPARDATG_PPRE_CIS_up
BromoxynilPPARGATG_PPRE_CIS_up
BromoxynilPPARGTOX21_PPARg_BLA_antagonist_ratio
BromoxynilPPARGATG_PPARg_TRANS_up
BromoxynilPTGER2BSK_LPS_PGE2_up
BromoxynilRORAATG_RORE_CIS_up
BromoxynilRORBATG_RORE_CIS_up
BromoxynilRORCATG_RORE_CIS_up
BromoxynilSAA1BSK_CASM3C_SAA_up
BromoxynilSELPBSK_4H_Pselectin_down
BromoxynilSOX1ATG_Sox_CIS_dn
BromoxynilAURKANVS_ENZ_hAurA
BromoxynilTP53TOX21_p53_BLA_p3_ratio
BromoxynilTP53TOX21_p53_BLA_p4_ratio
BromoxynilTP53TOX21_p53_BLA_p2_ratio
BromoxynilTP53TOX21_p53_BLA_p1_ratio
BromoxynilTP53TOX21_p53_BLA_p5_ratio
BromoxynilVCAM1BSK_4H_VCAM1_down
BromoxynilVDRATG_VDRE_CIS_up
BromoxynilXBP1ATG_Xbp1_CIS_up
BromoxynilNR1I2ATG_PXRE_CIS_up
BromoxynilCD38BSK_SAg_CD38_down
BromoxynilCD40BSK_LPS_CD40_down
BromoxynilCD40BSK_SAg_CD40_down
BromoxynilCD69BSK_SAg_CD69_down
BromoxynilNR1H4TOX21_FXR_BLA_antagonist_ratio

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.